An investigational treatment for myasthenia gravis, ARGX-113 (efgartigimod), being developed by the Dutch pharmaceutical firm argenx, was found to be…
Articles by Magdalena Kegel
Myasthenic crisis is a common complication in patients with myasthenia gravis (MG), marked by exacerbation of MG symptoms and respiratory…
The cost of Genentech’s myasthenia gravis treatment Rituxan (rituximab) is half that of the blood purification process known as plasmapheresis…
Removing the thymus is an effective way to treat people with ocular myasthenia gravis, according to an analysis of previously published data…
University of Southern California researchers have gained insight into how antibodies connected with a disease known as myasthenia gravis…